GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the LT1009 (sonepcizumab) antibody Fab fragment in complex with sphingosine-1-phosphate

Analyse Crystal structure of the LT1009 (sonepcizumab) antibody Fab fragment in complex… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3I9G
Type
protein
Length
435 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Sonepcizumab antibody Fab fragment, heavy chain; Sonepcizumab antibody Fab fragment…
Ligands
S1P, MG, CA
Pockets
3 · best druggability 0.56

Structure

x-ray diffraction · 2 distinct chains · 6% helix, 50% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
HSonepcizumab antibody Fab fragment, heavy chainprotein2227% helix, 50% strand—
LSonepcizumab antibody Fab fragment, light chainprotein2136% helix, 50% strand—

Ligands and binding sites

  • S1P · (2S,3R,4E)-2-amino-3-hydroxyoctadec-4-en-1-yl dihydrogen phosphate · ligand · chains H, L
  • MG · Magnesium ion · metal · 5 copies · chains L
  • CA · Calcium ion · metal · 2 copies · chains L

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11320.560.8223S1P
22790.510.7438empty
31500.430.7523empty

Interfaces

1 interface between chains.

  • H–L · 1820 Ų buried · 14 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 3I9G · Crystal structure of the LT1009 (SONEPCIZUMAB) antibody Fab fragment in complex with… · the same entry in another collection · chain H against H, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.